Find the latest pharmaceutical market place for formulations enquiry about Aflibercept on PharmaCompass.com.

Tender// Aflibercept (40 mg/ ml) Injections needed in Poland [ENA17938]

Miejskie Centrum Medyczne im. Dr. Karola Jonscher w Lodzi is looking for supplies of Aflibercept (40 mg/ ml) Injections for commercial purposes. The required quantity is 1,900 units. The deadline is 3-October-2023.

Reply

02 Sep 2023

SaudiArabia Flag

Various Finished Dosage Formulations needed in Saudi Arabia [ENA16888]

A leading company that focuses on the manufacturing of OSD, sterile, oral liquids, dry powder for suspension, creams, ointments & gels is looking for suppliers of Various Finished Dosage Formulations for commercial purposes. The suppliers must support this enquiry with CTD dossier & tech transfer.
1. Cyclosporin (0.05%) Eye Drops. The required quantity is 65,000 units
2. Aflibercept (2 mg/ 0.05 ml) Injections. The required quantity is 5,000 units.
3. Ranibizumab (0.5 mg) Injections. The required quantity is 5,000 units.
4. Isotretinoin (10 mg & 20 mg) Capsules. The required quantity is 25,000 units & 1 lakh units respectively.
5. Tacrolimus (0.1% & 0.03%) Ointments. The required quantity is 70,000 units & 20,000 units respectively.
6. Minoxidil (5%) Ointments. The required quantity is 1 lakh units.
7. Calcipotriol + Betamethasone (30 g) Ointments. The required quantity is 1 lakh units.
8. Dexlansoprazole (30 mg & 60 mg) Capsules. The required quantity is 10,000 units & 20,000 units respectively.

Reply

14 Apr 2023

Tender// Various Finished Dosage Formulations needed in Poland [ENA16034]

Szpital Uniwersytecki W Krakow is looking for supplies of Various Finished Dosage Formulations for commercial purposes. The deadline is 2-Feb-2023.
1. Darbepoetin Alfa (500 mcg/ ml) Solution for Injections. The required quantity is 1,600 units.
2. Aflibercept (40 mg/ ml) Solution for Injections. The required quantity is 900 units.

Reply

09 Jan 2023

Tender// Aflibercept (40 mg/ ml) Injections needed in Poland [ENA14832]

Municipal Medical Center dr. Karol Jonscher in Lodz is looking for supplies of Aflibercept (40 mg/ ml) Injections for commercial purpose. The required quantity is 1,800 units. The deadline is 8-Sep-2022.

Reply

27 Aug 2022

Tender// Aflibercept (40 mg/ ml) Solution for Injections needed in Poland [ENA13888]

Independent Public Healthcare Center of the Ministry of Interior and Administration in Szczecin is looking for supplies of Aflibercept (40 mg/ ml) Solution for Injections for commercial purpose. The required quantity is 500 units. The deadline is 4-Jul-2022.

Reply

07 Jun 2022

CzechRepublic Flag

Tender// Aflibercept (40 mg/ ml) Solution for Injection needed in Czech Republic [ENA12137]

Nemocnice Pardubickeho kraje, as is looking for supplies of Aflibercept (40 mg/ ml) Solution for Injection for commercial purpose. The required quantity is 2,940 units. The deadline is 7-Jan-2022.

Reply

16 Dec 2021

Netherlands1 Flag

Various Finished Dosage Formulations needed in Netherlands [ENA12029]

A company that deals in the distribution of various pharmaceutical products is looking for suppliers of various finished dosage formulations for commercial purpose.
1. Aflibercept (40 mg/ ml) Vials
2. Nadroparin (0.3 ml & 0.6 ml) Prefilled Syringes
3. Pegfilgrastim (6 mg) Prefilled Syringes

Reply

06 Dec 2021

Tender// Various Finished Dosage Formulations needed by Sykehusinnkjøp HF in Norway [ENA09241]

Sykehusinnkjøp HF, is looking for Various Finished Dosage Formulations. The suppliers must have a wholesale license or production license for its own preparations in the EEA at the time the tender is submitted. The deadline is 11-Jan-2021.
1. Ranibizumab (10 mg/ ml) Solution for Injection with Cannula. The required quantity is 582 units.
2. Ranibizumab (10 mg/ ml) Solution for Injection. The required quantity is 132 units.
3. Aflibercept (40 mg/ml) Solution for Injection. The required quantity is 29,057 units.

Reply

09 Dec 2020

unitedkingdom_new Flag

Various Finished Formulations needed in the United Kingdom [ENA06585]

A company that specialises in the supply of various medical equipment such as MRI scanners, CT scanners, ultrasound machines, dialysis consumables is looking for suppliers of Various Finished Formulations:
1. Aflibercept 100 mg/4 ml (5 Units) & 200 mg/8 ml (5 Units) Vials
2. Bevacizumab 100 mg/4 ml (15 Units) & 400 mg/16 ml (15 Units) Vials
3. Bimatoprost 0.01% (1,000 Units), 0.3 mg/mL (1,000 Units) Ophthalmic Solution
4. Bimatoprost 0.3 mg/ml + Timolol 5 mg/ml (400 Units) Ophthalmic Solution
5. Brimonidine 0.15% w/v (1,000 Units) Ophthalmic Solution
6. Brimonidine 2 mg + Brinzolamide 10 mg (1000 Units) Ophthalmic Solution
7. Brimonidine Tartrate 2 mg + Timolol maleate 5 mg (3000 Units) Ophthalmic solution
8. Brinzolamide 1% w/v (1,000 Units) Ophthalmic Solution
9. Brinzolamide 10 mg + Timolol maleate 5 mg (1000 Units) Ophthalmic solution
10. Cyclopentolate Hydrochloride 0.5% (200 Units) & 1% (200 Units) Ophthalmic Solution
11. Epinastine Hydrochloride 0.5 mg/ ml (2,000 Units) Ophthalmic Solution
12. Fluorometholone 0.1 % w/v + Neomycin 0.35 % w/v (232 Units) Ophthalmic solution
13. Latanoprost 50 mcg (400 Units) + Timolol Maleate 6.8 mg (400 Units) Ophthalmic Solution
14. Latanoprost 50 mcg (2000 Units) Ophthalmic Solution
15. Levobunolol 0.5% (1,000 Units) Ophthalmic Solution
16. Moxifloxacin Hydrochloride 5.45 mg/ml (2,000 Units) Ophthalmic Solution
17. Nepafenac 1 mg (1,000 Units) & 3 mg (1,000 Units) Ophthalmic Solution
18. Ofloxacin 0.3% w/v (81 Units) Ophthalmic Solution
19. Olopatadine 1 mg/ml (2,000 Units) Ophthalmic Solution
20. Polyethylene Glycol 400 0.4% + Propylene Glycol 0.3% (1,000 Units) Ophthalmic Solution
21. Polyvinyl Alcohol 1.4% (5,000 Units) Ophthalmic Solution
22. Povidone 0.6% (5,000 Units) Ophthalmic Solution
23. Prednisolone Acetate (microfine suspension) 1% (1,000 Units) Ophthalmic Solution
24. Travoprost 40 mcg/ml + Timolol Maleate 5 mg/ml (400 Units) Ophthalmic Solution
25. Timolol 6.8 mg (400 Units) Ophthalmic Solution
26. Travoprost 0.004 % (2,000 Units) Ophthalmic Solution

Reply

15 Feb 2020